Pregnancy in antiphospholipid syndrome: can we improve patient management?

Isr Med Assoc J. 2014 Oct;16(10):614-5.
No abstract available

MeSH terms

  • Abortion, Habitual* / etiology
  • Abortion, Habitual* / immunology
  • Abortion, Habitual* / prevention & control
  • Antibodies, Antiphospholipid / blood
  • Anticoagulants / therapeutic use*
  • Antiphospholipid Syndrome / complications
  • Antiphospholipid Syndrome / immunology
  • Antiphospholipid Syndrome / therapy
  • Antirheumatic Agents / therapeutic use*
  • Disease Management
  • Female
  • Fetal Death / etiology
  • Fetal Death / prevention & control
  • Humans
  • Immunomodulation*
  • Pregnancy
  • Pregnancy Complications* / immunology
  • Pregnancy Complications* / prevention & control
  • Pregnancy Outcome
  • Premature Birth / etiology
  • Premature Birth / immunology
  • Premature Birth / prevention & control
  • Risk Assessment
  • Thrombosis* / drug therapy
  • Thrombosis* / etiology
  • Thrombosis* / immunology
  • Treatment Outcome

Substances

  • Antibodies, Antiphospholipid
  • Anticoagulants
  • Antirheumatic Agents